Nourinovin, ShohrehShohrehNourinovinNavarro-Cia, MiguelMiguelNavarro-CiaRahman, Muhammad MMuhammad MRahmanPhilpott, Michael PMichael PPhilpottAbbasi, Qammer HQammer HAbbasiAlomainy, AkramAkramAlomainy2022-05-272022-05-272022-04IEEE Antennas and Propagation Magazine, 2022, 64 (2), pp.60-701045-9243http://hdl.handle.net/10044/1/97038According to a recent report [1] from the Cancer Research Agency of the World Health Organization, cancer is a dominant cause of mortality worldwide, leading to 10 million deaths in 2020 alone. Diagnosing a patient from the early stages tremendously raises the chance of survival. Current clinical cancer detection approaches including X-ray, magnetic resonance imaging (MRI), and biomarker analysis not only fail to provide a precise border of the malignant tissue, especially in the early stages of cancer, but also can be invasive and lead to tissue damage. Recent progress in EM biosensor technologies has the potential to deliver a point-of-care diagnosis and surpass conventional methods regarding accuracy, time, and cost.© 2022 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works.Science & TechnologyTechnologyEngineering, Electrical & ElectronicTelecommunicationsEngineeringTissue damageCostsMagnetic resonance imagingPoint of careOrganizationsCancer detectionSensorsPLASMONSARRAYSCELLSNetworking & Telecommunications0906 Electrical and Electronic Engineering1005 Communications TechnologiesJournal Articlehttps://www.dx.doi.org/10.1109/map.2022.3145712https://ieeexplore.ieee.org/document/97480391558-4143